Cargando…

Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?

Alzheimer’s disease (AD) is the most common dementia in the industrialized world, with prevalence rates well over 30% in the over 80-years-old population. The dementia causes enormous costs to the social healthcare systems, as well as personal tragedies for the patients, families and caregivers. AD...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreth, Jens, Mavoungou, Chrystelle, Schindowski, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681567/
https://www.ncbi.nlm.nih.gov/pubmed/23663286
http://dx.doi.org/10.1186/1742-4933-10-18

Ejemplares similares